Thermo Fisher Scientific (TMO) Partners With AIM ImmunoTech on Phase 3 Cancer Trial [Yahoo! Finance]
Thermo Fisher Scientific Inc (TMO)
Last thermo fisher scientific inc earnings: 4/22 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.thermofisher.com/investors/investor-overview/default.aspx
Company Research
Source: Yahoo! Finance
Thermo Fisher Scientific (TMO) Partners With AIM ImmunoTech on Phase 3 Cancer Trial On March 2, 2026, AIM ImmunoTech announced entering into an agreement with the PPD clinical research business of Thermo Fisher Scientific (TMO) to design a pivotal Phase 3 clinical trial for Ampligen. The study will evaluate the drug as a treatment for late-stage pancreatic cancer. It will utilize the Phase 2 results from the ongoing DURIPANC trial conducted with AstraZeneca. As pancreatic cancer remains a high-priority unmet medical need, AIM believes this strategic collaboration with Thermo Fisher Scientific Inc. (NYSE:TMO) offers the greatest growth potential for its stockholders. Separately, on March 11, 2026, U.S. President Donald Trump announced a visit to Thermo Fisher Scientific Inc. (NYSE:TMO) in Ohio. Trump highlighted the company's $2 billion investment in U.S. manufacturing and credited it to his “America First” trade and tariff policies. The investment will potentially repatriate high
Show less
Read more
Impact Snapshot
Event Time:
TMO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TMO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TMO alerts
High impacting Thermo Fisher Scientific Inc news events
Weekly update
A roundup of the hottest topics
TMO
News
- Clinical Trial Supplies Market to Reach USD 8.18 Billion by 2030 | MarketsandMarkets™ [TheStreet.com]TheStreet.com
- Thermo Fisher Scientific Completes Acquisition of Clario Holdings, Inc.Business Wire
- DNA?????? ???????? - ??????????????????2026-2035? [CNET News]CNET News
- Is Thermo Fisher Scientific (TMO) Pricing Look Attractive After Recent Share Price Weakness [Yahoo! Finance]Yahoo! Finance
- Artificial Intelligence Reshaping the Cell and Gene Therapy Manufacturing Landscape, New BCC Research Report Finds [Yahoo! Finance]Yahoo! Finance
TMO
Earnings
- 1/29/26 - Beat
TMO
Sec Filings
- 3/24/26 - Form 8-K
- 3/12/26 - Form 4
- 3/11/26 - Form 144
- TMO's page on the SEC website